Dendritic cells generated in the presence of interferon-α stimulate allogeneic CD4+ T-cell proliferation: Modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells

International Immunology

Volumn 16, Issue 7, 2004, Pages 1037-1052

  Carbonneil, Cédric ^a   Saidi, Héla ^a   Donkova Petrini, Vladimira ^a   Weiss, Laurence ^a,b  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

CD4 T cell subsets; Cytokines; T lymphocytes

Indexed keywords

ALLOANTIGEN; ALPHA INTERFERON; CD4 ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANTIGEN PURIFICATION; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL MATURATION; CELL POLARITY; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYSOSOME; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ANTIGENS, CD40; ANTIGENS, CD45; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-ALPHA; INTERLEUKIN-10; INTERLEUKIN-4; TH1 CELLS;

EID: 3242733207     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh106     Document Type: Article

References (44)

1. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
3. Caux, C., Ait-Yahia, S., Chemin, K., de Bouteiller, O., Dieu-Nosjean, M. C., Homey, B., Massacrier, C., Vanbervliet, B., Zlotnik, A. and Vicari, A. 2000. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22:345.
4. Lanzavecchia, A. 1998. Immunology, Licence to kill. Nature 393:413.
5. Ridge, J. P., Di Rosa, F. and Matzinger, P. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393:474.
6. Albert, M. L., Jegathesan, M. and Darnell, R. B. 2001. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2:1010.
7. Paquette, R. L., Hsu, N. C., Kiertscher, S. M., Park, A. N., Tran, L., Roth, M. D. and Glaspy, J. A. 1998. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J. Leukoc. Biol. 64:358.
8. Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T. and Belardelli, F. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191:1777.
9. Brassard, D. L., Grace, M. J. and Bordens, R. W. 2002. Interferon-alpha as an immunotherapeutic protein. J. Leukoc. Biol. 71:565.
10. Carbonneil, C., Aouba, A., Burgard, M., Cardinaud, S., Rouzioux, C., Langlade-Demoyen, P. and Weiss, L. 2003. Dendritic cells generated in the presence of GM-CSF and Interferon-alpha are potent inducers of HIV-specif ic CD8+ T cells. AIDS 17:1731.
11. Padovan, E., Spagnoli, G. C., Ferrantini, M. and Heberer, M. 2002. IFN-alpha 2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8(+) effector T cells. J. Leukoc. Biol. 71:669.
12. McRae, B. L., Nagai, T., Semnani, R. T., van Seventer, J. M. and van Seventer, G. A. 2000. Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood 96:210.
13. Ito, T., Amakawa, R., Inaba, M., Ikehara, S., Inaba, K. and Fukuhara, S. 2001. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166:2961.
14. Caux, C., Massacrier, C., Vanbervliet, B., Barthelemy, C., Liu, Y. J. and Banchereau, J. 1994. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int. Immunol. 6:1177.
15. Morel, A. S., Quaratino, S., Douek, D. C. and Londei, M. 1997. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur. J. Immunol. 27:26.
16. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. and Enk, A. H. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
17. Steinbrink, K., Jonuleit, H., Muller, G., Schuler, G., Knop, J. and Enk, A. H. 1999. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93:1634.
18. Mohty, M., Vialle-Castellano, A., Nunes, J. A., Isnardon, D., Olive, D. and Gaugler, B. 2003. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. J. Immunol. 171:3385.
19. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M. and Trinchieri, G. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
20. Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M. and Modlin, R. L. 1996. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J. Clin. Invest. 97:2130.
21. Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S. and Levings, M. K. 2001. Type 1 T regulatory cells. Immunol. Rev. 182:68.
22. Corinti, S., Albanesi, C., la Sala, A., Pastore, S. and Girolomoni, G. 2001. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166:4312.
23. Kaser, A., Nagata, S. and Tilg, H. 1999. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Cytokine 11:736.
24. Parlato, S., Santini, S. M., Lapenta, C., Di Pucchio, T., Logozzi, M., Spada, M., Giammarioli, A. M., Malorni, W., Fais, S. and Belardelli, F. 2001. Expression of CCR-7, MIP-3beta and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 98:3022.
25. Paquette, R. L., Hsu, N., Said, J., Mohammed, M., Rao, N. P., Shih, G., Schiller, G., Sawyers, C. and Glaspy, J. A. 2002. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo. Leukemia 16:1484.
26. Gabriele, L., Borghi, P., Rozera, C., Sestili, P., Andreotti, M., Guarini, A., Montefusco, E., Foa, R. and Belardelli, F. 2004. IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment. Blood 103:980.
27. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P. and Tough, D. F. 2003. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4:1009.
28. Ruckert, R., Brandt, K., Bulanova, E., Mirghomizadeh, F., Paus, R. and Bulfone-Paus, S. 2003. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur. J. Immunol. 33:3493.
29. Pulendran, B., Dillon, S., Joseph, C., Curiel, T., Banchereau, J. and Mohamadzadeh, M. 2004. Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo. Eur. J. Immunol. 34:66.
30. Akbar, A. N., Salmon, M., Ivory, K., Taki, S., Pilling, D. and Janossy, G. 1991. Human CD4+CD45R0+ and CD4+CD45RA+ T cells synergize in response to alloantigens. Eur. J. Immunol. 21:2517.
31. Carbonneil, C., Donkova-Pétrini, V., Aouba, A. and Weiss, L. 2004. Defective dendritic cell function in HIV-infected patients receiving effective HAART: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell reponses induced by dendritic cells generated in the presence of IFN-alpha. J. Immunol. In press.
32. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H. and de Vries, J. E. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
33. Ancuta, P., Weiss, L. and Haeffner-Cavaillon, N. 2000. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur. J. Immunol. 30:1872.
34. Aman, M. J., Tretter, T., Eisenbeis, I., Bug, G., Decker, T., Aulitzky, W. E., Tilg, H., Huber, C. and Peschel, C. 1996. Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood 87:4731.
35. Morel, A. S., Coulton, G. and Londei, M. 2002. Regulation of major histocompatibility complex class II synthesis by interleukin-10. Immunology 106:229.
36. de Saint-Vis, B., Vincent, J., Vandenabeele, S., Vanbervliet, B., Pin, J. J., Ait-Yahia, S., Patel, S., Mattei, M. G., Banchereau, J., Zurawski, S., Davoust, J., Caux, C. and Lebecque, S. 1998. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9:325.
37. Dondi, E., Rogge, L., Lutfalla, G., Uze, G. and Pellegrini, S. 2003. Down-modulation of responses to type I IFN upon T cell activation. J. Immunol. 170:749.
38. Inaba, M., Kurasawa, K., Mamura, M., Kumano, K., Saito, Y. and Iwamoto, I. 1999. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J. Immunol. 163:1315.
39. Di Somma, M. M., Somma, F., Montani, M. S., Mangiacasale, R., Cundari, E. and Piccolella, E. 1999. TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis. J. Immunol. 162:3851.
40. Horwitz, D. A., Zheng, S. G. and Gray, J. D. 2003. The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets. J. Leukoc. Biol. 74:471.
41. Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R. and Roncarolo, M. G. 2001. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166:5530.
42. Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., Mancini, D. and Suciu-Foca, N. 2003. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11:245.
43. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F. and Tough, D. F. 2001. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14:461.
44. Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Suzuki, T., Miyagi, T. and Hayashi, N. 2003. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J. Immunol. 171:5423.